At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad The SERD spectacle, the VERIFY study, and the dream of a better multi-cancer liquid biopsy test

https://www.statnews.com/2025/06/01/asco-cancer-biotech-news-astrazeneca-genentech-roche-takeda-bristol-chicago/